Patriot Scientific (899459) bekommt ihr Recht..
am 03.03. JVC (verlegt vom 10.02.).
Meines Erachtens wird sich die Aktie spätestens an diesen Tagen wieder weiter auf in Richtung Norden machen. Interessant wird sein, ob und wie stark die japanischen Unternehmen zur Kasse gebeten werden, oder ob es vorher (vielleicht ja morgen) noch einen "friedlichen" Vergleich gibt :-)
So oder so, vielversprechende Aussichten!
Good trades, Gruß
salo
Gleich (und morgen) werden viele den Kursen wieder hinterher laufen...
Kurs wird heute bestimmt noch nach oben ziehen...we will see
Gruß, salo
plötzlich "verschwunden".
Meiner Meinung kann das nur bedeuten, dass Ptsc wahrscheinlich eine außergerichtliche Einigung mit Panasonic getroffen hat.
Ob diese Meldung heute noch bekannt gegeben wird bleibt abzuwarten...möglich wäre es.
Dann wollen wir mal schauen, was den Japanern so abgeknöpft wird :-)
Gruß, salo
Patriot Scientific Corporation Announces Debenture Conversion, Warrant Buyback Agreements
Friday February 10, 9:30 am ET
Debentures Being Retired - Redemption of up to 20 Million Warrants Authorized
SAN DIEGO--(BUSINESS WIRE)--Feb. 10, 2006--Patriot Scientific Corporation (OTC Bulletin Board: PTSC.OB - News) -- a high-tech intellectual properties company that specializes in developing and licensing high-performance ultra-low power microprocessor technology -- today announced that it has entered into agreements to reorganize its relationship with Lincoln Ventures, LLC ("Lincoln") and Swartz Private Equity, LLC ("Swartz") to benefit the Company and its retail shareholders. The agreements, which are subject to Board approval, provide for the following:
Lincoln and Swartz will immediately convert their remaining convertible debentures of the Company, following which the Company will not have any debt on its balance sheet.
To facilitate the conversion of the debentures, agreements between the Company and Lincoln and Swartz which prohibit each of Lincoln and Swartz from owning more than 4.99% of the Company's Common Stock will be amended to allow them to own up to 9.99% of the Common Stock. With their holdings exceeding 5% they will need to make appropriate SEC filings upon future dispositions of the Company's stock.
The Company will have the right to redeem up to 20 million warrants owned by Lincoln and Swartz.
The exercise prices of Company warrants held by Lincoln and Swartz will no longer be subject to downward resets based on the trading price of the Company's Common Stock.
The Company will issue 7,000,000 warrants to Lincoln and Swartz in consideration for the agreements.
The agreements were negotiated directly with Lincoln Ventures, LLC, and Swartz Private Equity, according to Patriot Scientific Chairman and CEO David Pohl. "These agreements are an important step toward freeing the Company from the burden of certain debt and equity financing transactions that enabled the Company to remain viable in previous years," Pohl stated. "During the past 12 months the Company has undergone significant changes in management and operating strategy and is now in a favorable cash position as a result of licensing revenues related to our patent portfolio that is jointly owned with the TPL Group. We are pleased that the principals of the Swartz and Lincoln organizations were willing to provide financing in the past and that they are now demonstrating their confidence in the future of Patriot Scientific by entering into these new agreements."
The warrant buyback program is based upon an agreement which calls for a structured series of warrant redemptions over a period of several months, beginning in February 2006. "Under the terms of this agreement we have the right but not the obligation to redeem up to 2 million warrants per month," Pohl continued, "and we are pleased to have negotiated a redemption price that is equal to each applicable volume weighted average monthly trading price for Patriot's shares less the exercise price for the first 10 million warrants covered by this agreement." The price and terms applicable to the redemption of the other 10 million warrants will be determined by mutual agreement of the parties.
A spokesman for Lincoln Ventures, LLC and Swartz Private Equity, LLC, announced that "Lincoln and Swartz are pleased with the progress of Patriot's intellectual property enforcement program through its joint venture portfolio partner, The TPL Group. We have confidence in their program to secure additional licensing transactions with users of the patented technologies of Patriot and TPL, and the potential for sustained revenue to the Company."
"At Patriot's request," the spokesman continued, "both Lincoln and Swartz have agreed to convert all of their outstanding Patriot Scientific debentures into shares of common stock. These conversions will result in our beneficial ownership exceeding 5% of the issued and outstanding shares of Patriot, and as a result we will make all appropriate SEC filings as to the future disposition of our holdings of the Company's common stock. We trust that these actions will support Patriot Scientific in its growth as Patriot and TPL accelerate their worldwide licensing of the jointly owned MMP Portfolio."
The action by Patriot Scientific to retire the debentures and to also buy back what could amount to approximately 20 percent of the company's total outstanding stock warrants at this juncture was driven by the same impetus that has guided other strategic reorganizational moves that began in 2005. Last year the Company changed both its executive team and the Company's strategic direction, including the signing of a significant agreement with The TPL Group regarding joint ownership and marketing of its patent portfolio.
Patriot Scientific received licensing revenues of $13 million in 2005. The Company received distribution of an additional $10 million in January of 2006 as a result of a license transaction with systems manufacturer HP regarding Patriot's jointly owned patent portfolio.
"The far-reaching changes in 2005 helped pave the way for new growth-oriented initiatives in 2006, including the fiscal strengthening evidenced by these important agreements," Pohl said. "These changes are positive for Patriot," he continued. "We are moving forward, sometimes more slowly or with smaller steps than we would like, but always with the paramount goal of enhancing shareholder value by prudently addressing company fundamentals and growing the business."
About Patriot Scientific
Patriot Scientific (OTC Bulletin Board: PTSC.OB - News) has emerged as an effective and dynamic intellectual property licensing company, developing and marketing innovative and proprietary semiconductor technologies. The Company's portfolio of proprietary designs encompasses what is believed to be fundamental ultra-low-power array microprocessor technology, as well as pending patents designed to protect Patriot's proprietary technology.
Detailed information about Patriot Scientific can be found on the website www.ptsc.com. Copies of Patriot Scientific press releases, current price quotes, stock charts and other valuable information for investors may be found at www.hawkassociates.com and www.americanmicrocaps.com. An investment profile on Patriot Scientific may be found at http://www.hawkassociates.com/patriot/profile.htm.
About the Patent Portfolio
The patent portfolio, marketed as the MMP portfolio, contains intellectual property that became jointly owned by Patriot Scientific Corporation and the privately held TPL Group in a settlement between them in June 2005. Both TPL and Patriot assert that their jointly owned patents have long been essential to the design of advanced microprocessors, digital signal processors, embedded processors and system-on-chip devices. Global sales of end products deploying chips using technologies protected by the jointly owned patents are estimated to be greater than $200 billion annually.
The MMP Portfolio is exclusively managed by Alliacense, a TPL Group enterprise. Following the early purchase of MMP Portfolio licenses by marquee chip makers Intel and AMD, Alliacense has tuned the MMP Portfolio Licensing Program to serve leading manufacturers of computer, communications and entertainment systems. Today's consumer electronics and computer systems each incorporate an increasing number of microprocessors that exploit the techniques protected by the MMP Portfolio. These include a wide variety of end-user products including personal computers, servers, workstations, printers, routers, home theater systems, digital TVs, video game players, DVD Recorders/Players, mobile handsets, portable media players, automotive and aircraft/aerospace electronics, and most other modern microprocessor-based products.
Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: Statements in this news release looking forward in time involve risks and uncertainties, including the risks associated with the effect of changing economic conditions, trends in the products markets, variations in the company's cash flow, market acceptance risks, technical development risks, seasonality and other risk factors detailed in the company's Securities and Exchange Commission filings.
Contact:
Patriot Media Relations, San Diego
Attention Group
Daryl Toor, 770-777-9489
dtoor@attentiongroup.com
or
Patriot Investor Relations
Hawk Associates
Frank Hawkins/Julie Marshall, 305-451-1888
info@hawkassociates.com
--------------------------------------------------
Source: Patriot Scientific Corporation
Salomo, ich glaube auch an einen Vergleich. Kann mir einfach nicht vorstellen, dass diese Firmen auf ein Urteil warten.
Mittlerweile bin ich ja nun auch schon eine ganze Weile bei PTSC dabei und ehrlich gesagt verstehe ich nicht wirklich, warum das Teil noch bei ein paar Cents rumdümpelt. Nachdem erst AMD und dann Intel ein paar Milliönchen abgedrückt hatten war die Sache eigentlich mehr als klar. Wenn diese eine billigere Möglichkeit gesehen hätten, dann hätten sie diese auch genutzt. An den Patenten ist also definitiv was dran. Es ist also nicht mehr die Frage, OB die anderen zahlen, sondern nur noch WANN. Die ersten hatten noch eine Art Bonus gegenüber der kleinen, unbekannten Patriot Scientific Corp., aber das hat sich mittlerweile wohl grundlegend geändert und ab nun werden die Verklagten wohl nicht mehr so billig davon kommen. Die Summen werden schon größer. Ich würde durchschnittlich von mindestens 10-20 Mio $ pro verklagter Partei ausgehen - eher mehr und ausserdem mit weiteren, jährlichen Zahlungen rechnen. Es ist nicht umsonst die Rede von einem Patentwert von 200 Milliarden $. Selbst, wenn man sich am Ende nur auf 50 bis 100 Mia. mit allen einigt und PTSC davon nur die Hälfte oder ein Drittel für sich rausschlagen kann (TPL usw. wollen auch ihren Teil...), dann ist selbst die damalige Rambus-Story nur Pillepalle im Vergleich zu PTSC.
Nun wie komme ich nun auf die 1,5 Milliarden: Ganz einfach, auf der Liste stehen Rund 150 Firmen, zahlt jede nur den Discountpreis von 10 Millionen wie HP, dann sind das 1,5 Milliarden.
Zahlen müssen früher oder später alle - wann, weiß niemand.
Die 1,5 Milliarden als Börsenwert betrachtet entsprechen einem Aktienkurs von ungefähr 4USD. Selbst der wäre kaum realistisch, sollten die das Geld dann tatsächlich in bar rumliegen haben.
Viele Grüße Abenteurer
gewaltige Kurssprünge geben wird. Vielen Anlegern ist die Chance noch nicht ganz
klar geworden...
Mensch, das war ein Miniladen...dann kamen INTEL(!), AMD(!), HP (!) und haben alle schön gezahlt. Was meint ihr denn, wie es den anderen dann wohl ergeht...
Die Entwicklung die PTSC jetzt macht kann wirklich außerordentlich sein..
Ich freue mich der Dinge, die da noch kommen werden...
Gruß, salo
unbenannt.bmp
warum sollte sich AMD sonst in eine (damals) mit 30 Mio. USD bewertete "Klitsche" einkaufen? Das der Kurs noch rumdümpelt verwundert mich auch nicht, denn der Normale Anleger hat schlicht und einfach keine Ahnung. Ein Blick in die amerikanischen Boards: http://ragingbull.lycos.com/mboard/...PTSC&origsymbols=PTSC zeigt recht deutlich, wie gebildet der Anleger wirklich ist:
Alle Argumente die die short Investierten vorbringen, sind 100 Millionen (noch nicht auf dem Markt befindliche) genehmigte Aktien.
Meistens dauert es etwas, bis man an der Börse recht bekommt - Kontostände kann man aber irgendwann nicht mehr ignorieren.
Ich freu mich auch auf das was noch kommt.
Abenteurer
nein, einfache eine gute Basis.
Viele Grüße Abenteurer
Aus dem Agoracom-Board:
http://www.agoracom.com/nonmemforum/...99&refid=0&orig=448399
Subject: The ''big picture'', near term and long term....
From ronran
PostID 448399 On Sunday, February 12, 2006 (EST) at 2:25:22 PM
--------------------------------------------------
I spoke with Brian about the recent PR and the status of the litigation, and although I initially thought I would wait awhile to write these comments, I reconsidered in view of the possibilty that we could get a quick decision from Judge Jenkins. This is likely to be a long post, so please accept my apologies in advance.
As I have mentioned various times over the last couple of weeks, we are IMO at much the same juncture, by analogy, as we were last summer prior to the Higgins ruling. People are getting pumped up and excited, we are seeing stock price estimates of several dollars, and everyone is just waiting for the ship to come in because many have deemed it a foregone conclusion that the case will stay in Texas. All of this could certainly happen and I want to be the first guy in line if it does --- but I remember the gnashing of teeth when the Higgins debacle occurred, so I thought discussing these issues now, and in what I consider to be the appropriate context, might provide some perspective.
First, it is NOT a good thing IMO that Judge Ward in Texas has agreed to either ''stay'' or ''defer''. More on this in a moment, but even those two terms mean different things --- ''stay'' means ''wait and see'', while ''defer'' means that Judge Ward intends, in effect, to be bound by the decision of the California court. I have not seen the actual language used but neither is great for PTSC, although I must say that this is not unexpected --- the cases did start out in California, PTSC is located in that venue, and speaking just from common sense, there probably are more ''contacts'' of the type required by law in California than in Texas. Many of you will recall my comment, back when the Texas case was first filed, that we would see challenges from the defendants on these issues.
How will the California court rule? I surely do not know. It could well be, as with many federal judges, that Judge Jenkins merely sees a chance to clear up a docket and send the ''problem'' elsewhere --- on the other hand, California courts are normally ''big business friendly'' in the tech arena (otherwise, the J4 wouldn't be fighting to get these cases back there), so perhaps that will be a factor. As always, we shall see.
What I can tell you without any hesitation is that, even if we get an unfavorable ruling on this particular issue, that does NOT mean that the case has been lost on the infringement issue --- it simply means that we will be moving forward in California. In and of itself, while not as good as being in Texas, litigating in California also does NOT automatically mean that PTSC will lose --- our attorneys, Townsend & Townsend, are very well respected there, and the case will ultimatley be decided by a jury, not by Judge Jenkins.
But let's move even farther forward and make some other unfavorable assumptions --- let's assume, just hypothetically, that Patriot does lose the case in California and that the J4 get off ''scott free''. What happens then? Well, that certainly wouldn't be a wonderful thing, but remember --- just because such a result would mean that the J4 didn't infringe, it would have NOTHING to do with the other 140+ alleged infringers that are still out there. And likely, at least some of those other alleged infringers could probably be sued outside California, perhaps in Texas or even at another venue of PTSC's choice.
So, the bottom line is that, if Judge Jenkins or some other California judge rules against PTSC on this threshold issue, the negative perception will almost undoubtedly send the stock price down, a la' the Higgins scenario --- there is really no factual reason why that should occur, but it probably will, since in the markets, perception controls over reality. The good news is that, if such a thing occurs,
None of this is meant to sound unduly negative about our chances with Judge Jenkins or, if we lose the present issue, about our chances of winning on the merits in California. As above, we have well-respected and able patent counsel (as opposed to Beatie), and it may be that we will be able to count on witnesses from Intel, AMD, and H-P if the case goes to trial. The point of all of the above is that it ain't over til it's over, and all of us need to keep that in mind. I'll be disappointed, too, if the case is sent out of Texas, but it won't be the end of the world.
As to the PR a few days ago, I haven't had a chance to analyze it in detail, but I do think it is a step in the right direction. Although Mr. Swartz still has plenty of warrants with which to affect our stock price, he appears to be taking on more of a role as a ''true long'', and that cannot be a bad thing.
Everyone have a great Sunday afternoon.
Daily Commentary
Our system posted a BUY-IF today. The previous SELL recommendation was issued on 02.09.2006 (1) day ago, when the stock price was 0.2100. Since then PTSC has gained 7.62% .
A bullish pattern has developed and a BUY-IF alert is issued today. You will also see if we erred badly in our previous SELL signal. So a warning is in order. Confirmation in the next session means that the signal failed. This failure amounts to missing a significant bullish opportunity. You can, however, still ride on a back wagon of the bullish train by following the guidelines below. The task is now to confirm the validity of this bullish pattern. We will guide you through this process but the prime star of this game is nobody but you. First you must do your homework. A good starting point may be to keep an eye on after-hours and futures trading to get preliminary hints about the direction of the market. Related news, events, economic data, and the world stock markets should also be closely followed prior to confirmation session.
There are three possible cases of confirmation. You have to follow the next session carefully to check if these cases will hold or not:
The market opens with an upward gap, signaling a bullish sentiment in the first case. Your benchmark will be the opening price. If the prices stay over the benchmark, go long. Any white candlestick with an upward gap is a valid confirmation criterion.
In the second case, the market opens at a level, equal to or below the previous day’s close. The benchmark is that closing price. If prices during the session stay over the benchmark, go long. Any white candlestick closing above the previous day’s close is the second confirmation criterion.
If, however, in both cases, the prices during the session start coming below the benchmark, avoid buying. Sell if you feel a definite tendency in prices to close the day below the benchmark.
The third case of confirmation is rarely observed. The market opens with a big downward gap suggesting a very bearish day, and the day ends with a long white candlestick, but still closing below the previous day’s close. However, such a day satisfies the third confirmation criterion and in this case the closing price of the long white candlestick will be taken as the price of confirmation.
If one of the three confirmation criteria is not fulfilled, or in case of a black candlestick or a doji on the confirmation day, the BUY-IF alert remains valid, however without confirmation and the three confirmation criteria are then sought in the following day. The only exception is the long black candlestick. Any long black candlestick following a BUY-IF alert makes it (the signal) void and invalid.
Do not consider any new short positions given the bullish alert and the recent bullish momentum. Short sellers must cover their positions to prevent further losses, especially if the market confirms the BUY-IF signal, in which case we owe you an apology about the previous SELL signal.
http://www.americanbulls.com/StockPage.asp?CompanyTicker=PTS...
oder geht noch was ??
aussteigen oder drinnen bleiben, das ist hier die frage ??
Antwort ??
Bin für jede Meinung dankbar
Rolli20
die waren allerdings von Freitag,
bleibe aber weiterhin dabei, Risiko,
Ich für meinen Teil spekuliere hier nicht auf 50 oder 100% Prozent, sondern darauf, dass Patriot S. an der Börse mit dem Wert bewertet wird, den ich diesem Unternehmen zuschreibe. (Jeder muss das für sich selbst klären.) Ganz besonders wichtig ist es bei einer derartigen Spekulation, dass man das Kapital mit dem man sich daran beteiligt, unbefristet zur Verfügung stehen hat, ja notfalls abschreiben kann, ohne Haus und Hof zu verlieren. Niemand kann sagen ob und wann es zu einer Gerichtsentscheidung, einer außergerichtlichen Einigung oder einfach geschlossenen Lizenzvereinbarungen kommt.
Prinzipiell halte ich von Tagespekulationen nichts, da kann man gleich ins Casino gehen und auf rot oder schwarz setzen: Ganz besonders bei einer solchen Aktie, die in Deutschland relativ geringe Umsätze aufweist, glaube ich dass es doppelt riskant ist.
Viele Grüße Abenteurer
FUJITSU COMPUTER, et al. v. PATRIOT SCIENTIFIC CORP <?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />
Tuesday 02/14/2006
09:30 AM C05-04837 MJJ e-filing
FUJITSU COMPUTER, et al. v. PATRIOT SCIENTIFIC CORP., et al.
Pla: Harold McElhinny ( )
Def: Roger Cook ( ), Floyd Saunders ( )
Defendants' Motion to Dismiss, Stay or Transfer
[OFF CALENDAR - Stipulation to Continue filed]
http://www.cand.uscourts.gov/cand/calendar.nsf/0/...ea6a?OpenDocument
Was diese Worte "Stipulation to Continue filed" bedeuten kann ich nicht sagen - auch in den amerikanischen Boards ist man unschlüssig.
Oder habe ich etwas nicht mitbekommen....
B.
Wie schon gesagt, niemand weiß was.
http://www.agoracom.com/nonmemforum/...54&refid=0&orig=448554
Subject: ptsczza.....
From ronran
PostID 448554 On Monday, February 13, 2006 (EST) at 12:23:35 PM
--------------------------------------------------
I am just back in the office from court, so I haven't seen the trading pattern since the open. However, unless my realtime system is in erro (which has been occuring to some extent lately) I am now showing the stock down to .21, about 7%, on decent volume as compared to recent sessions. Frankly, I don't know what to make of that except that it is at least partially attributable to the uncertainty of the CA/TX issue.
As to whether we will get a quick decision out of CA, that is anyone's guess. I alluded that in my post last evening, i.e., whether the judge will merely want to get the case off his docket and let it move forward in TX, or whether he will really consider all of the issues, which are complex.
It does concern me a bit that, according to someone else who posted earlier this morning, there has been a CMC scheduled in CA. Although this would make one tend to think that there will be further proceedings there, it is also true that CMCs are often set on an ''automatic'' basis by the clerk's office. And, in any event, the date was far enough out to allow for lots of settlement negotiations in between.
Sorry, but everything is up in the air at this point, and there is no way to really come to any intelligent conclusions. We'll just have to be patient.
E-mail | Print | | Disable live quotes Last Update: 9:42 AM ET Feb 14, 2006
SAN DIEGO, Calif., Feb 14, 2006 (BUSINESS WIRE) -- In a move virtually unprecedented among Microcap stocks, Patriot Scientific Corporation (OTCBB: PTSC.OB) - a high-tech intellectual properties Company that specializes in developing and licensing high-performance ultra-low power microprocessor technology - today announced that it will issue a cash dividend of $0.02 per share of common stock for shareholders and qualified warrant holders of record as of February 24, 2006. The dividend is payable March 22, 2006.
This dramatic announcement follows closely on the heels of the Company's announcement last week of a buy-back program for up to 20 million stock warrants and the conversion and retirement of all outstanding debentures. Final information as to the number of shareholders and outstanding shares will be provided by the Company's transfer agent as of the record date, but based upon current information and estimates the Company will set aside funds of approximately $7million or more for payment of the dividend from its currently available cash and cash equivalents that amount to approximately $17 million.
This announcement is especially significant because - until less than 12 months ago - Patriot had never shown a quarterly profit, and had never realized significant revenue from its 10-patent portfolio of seminal microprocessor innovations. Since February of last year, the Company's jointly owned patent portfolio has been successfully licensed to Intel, HP and AMD - in the process, generating nearly $24 million in revenue for Patriot. Based on these licenses and other key factors covered in recent SEC filings, Patriot Scientific currently has a market cap of approximately $64 million dollars.
With these successful license negotiations as precedent, the Company - through its marketing alliance with The TPL Group's Alliacense division, - is actively and confidently negotiating for licenses with other U.S. and foreign companies whose products include high speed microprocessors - more than 150 of which were put on notice of likely infringement - and that includes practically every high-tech consumer electronics manufacturer and systems integrator in the global marketplace.
"We are pleased to be in the strong financial position that enables us to offer our loyal shareholders this significant dividend," said David H. Pohl, Chairman and CEO of Patriot Scientific. "The Company strongly believes that more licensing deals and related revenues are likely, although none are assured," Pohl continued. "Patriot Scientific's Board of Directors will consider and decide whether to take such dividend payment actions in the future, based on future revenues and the financial condition of the Company, as well as market conditions and other factors."
Pohl also said that, "This dividend payment, which is rare in the arena of microcap companies, is another important step toward evidencing Patriot Scientific's current financial strength and the fact that the Board and management firmly believe in the Company's future potential. During the past 12 months, the Company has undergone significant changes in management and operating strategy. As a result of those changes and the licensing revenues related to our jointly owned patent portfolio we are now in a favorable cash position, and we are using some of that cash to pay out our first-ever dividend to shareholders."
The action by Patriot Scientific to issue this dividend - and also last week's decision to retire the debentures and buy back what could amount to up to approximately 20 percent of the Company's total outstanding stock warrants at this juncture - were driven by the same impetus that has guided other strategic re-organizational moves that began in 2005. Last year the Company changed both its executive team and the Company's strategic direction, including the signing of a significant agreement with The TPL Group regarding joint ownership and marketing of its patent portfolio.
Patriot Scientific received licensing revenues of $13 million in 2005. The Company received distribution of an additional $10 million in January of 2006 as a result of a license transaction with systems manufacturer HP regarding Patriot's jointly owned patent portfolio.
"The far-reaching changes in 2005 helped pave the way for new growth-oriented initiatives in 2006," Pohl said. "These changes are positive for Patriot. We continue to move forward with the paramount goal of enhancing shareholder value by prudently addressing Company fundamentals and growing the business."